Cornerstone Capital Management Holdings’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-5,216	Closed	-$279K	–	1616
2016 Q1	$279K	Sell	5,216 -1,400	-21%	-$103K	﹤0.01%	1155
2015 Q4	$747K	Buy	6,616 +616	+10%	+$67.9K	0.01%	959
2015 Q3	$706K	Buy	6,000 +1,300	+28%	+$170K	0.01%	935
2015 Q2	$364K	Buy	4,700 +2,400	+104%	+$157K	﹤0.01%	1071
2015 Q1	$133K	Sell	2,300 -3,000	-57%	-$127K	﹤0.01%	1235
2014 Q4	$171K	Buy	+5,300	New	+$159K	﹤0.01%	1111

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Cornerstone Capital Management Holdings's ANAC Position: Q2 2016 in Review

Cornerstone Capital Management Holdings sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 5,216 shares — an estimated $279K sold.

Cornerstone Capital Management Holdings first reported a position in ANAC in Q4 2014 and held it in 6 quarters. The position peaked at $747K in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Cornerstone Capital Management Holdings reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Cornerstone Capital Management Holdings sold 5,216 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $279K.
Cornerstone Capital Management Holdings first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2014 and held it in 6 quarters.
Cornerstone Capital Management Holdings's ANACOR PHARMACEUTICALS INC COM position peaked at $747K in Q4 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Cornerstone Capital Management Holdings's 13F filing for Q2 2016, filed 12 Aug 2016.